Track OSE Immunotherapeutics S.A.'s total assets ($78M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2025), ORPOF shows a total assets of $78M. That compares with $120M in the prior-year period — down 36.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ORPOF's total assets is now $78M (was $120M) — a 36.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether OSE Immunotherapeutics S.A. is outperforming or lagging.
Tracking ORPOF's total assets over time shows whether OSE Immunotherapeutics S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $78M That compares with $120M in the prior-year period — down 36.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has OSE Immunotherapeutics S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $78M) with ownership activity and broader fundamentals.
OSE Immunotherapeutics S.A.'s total assets is $78M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.